PeptiMatrix
Signal active
Organization
Contact Information
Overview
We are a team of matrix biologists, cancer scientists, toxicologists, and biomaterial engineers who have worked together to develop an innovative, animal-free solution for 3D cell culture.
We have done this with the support of the NC3Rs, BBSRC, and EPSRC. By combining the skills and expertise of individuals across a broad range of scientific backgrounds we are able to develop technologies that address a variety of unmet challenges in 3D in vitro modelling.
Our mission is to provide researchers a better way to model development and disease that is more reproducible, reliable, and ethical.
To learn more, visit www.peptimatrix.com
About
Industries
Biotechnology, Life Science
Founded
2023
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
PeptiMatrix headquartered in Europe, operates in the Biotechnology, Life Science sector. The company focuses on Biotechnology and has secured $3.5M in funding across 8 round(s). With a team of 1-10 employees, PeptiMatrix is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - PeptiMatrix, raised $435.5K. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
2
Lead Investors
0
Total Funding Amount
$435.5K
Details
0
PeptiMatrix has raised a total of $435.5K in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
PeptiMatrix is funded by 4 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| PeptiMatrix | - | FUNDING ROUND - PeptiMatrix | 435.5K |
| Innovate UK | - | FUNDING ROUND - Innovate UK | 435.5K |
| PeptiMatrix | - | FUNDING ROUND - PeptiMatrix | 435.5K |
| University of Nottingham | - | FUNDING ROUND - University of Nottingham | 435.5K |
Recent Activity
There is no recent news or activity for this profile.